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ABSTRACT Islet amyloid polypeptide (IAPP) is a pancreatic hormone and one of a number of proteins that are involved in the
formation of amyloid deposits in the islets of Langerhans of type II diabetesmellitus patients. Though IAPP-membrane interactions
are known to play amajor role in the ﬁbrillation process, themechanismand the peptide’s conformational changes involved are still
largely unknown. To obtain new insights into the conformational dynamics of IAPP upon its aggregation at membrane interfaces
and to relate these structures to its ﬁbril formation, we studied the association of IAPP at various interfaces including neutral aswell
as charged phospholipids using infrared reﬂection absorption spectroscopy. The results obtained reveal that the interaction of
human IAPP with the lipid interface is driven by the N-terminal part of the peptide and is largely driven by electrostatic interactions,
as theprotein is able to associate stronglywith negatively charged lipidsonly.A two-stepprocess is observeduponpeptidebinding,
involvingaconformational transition froma largelya-helical to ab-sheet conformation, ﬁnally formingorderedﬁbrillar structures. As
revealed by simulations of the infrared reﬂection absorption spectra and complementary atomic force microscopy studies, the
ﬁbrillar structures formed consist of parallel intermolecular b-sheets lying parallel to the lipid interface but still contain a signiﬁcant
number of turn structures. We may assume that these dynamical conformational changes observed for negatively charged lipid
interfaces play an important role as the ﬁrst steps of IAPP-induced membrane damage in type II diabetes.
INTRODUCTION
Protein ﬁbrils are involved in intra- and extracellular func-
tions, such as movement, cell deformation and division, and
blood clotting (1). However, aggregation and subsequent
amyloid formation are also a central phenomenon in a number
of diseases, such as Alzheimer’s and Parkinson diseases, type
II diabetes mellitus (TIIDM), and prion disorders (2–5), and
seem to be the key factors in the development of the symptoms
of these diseases. Upon formation of amyloid ﬁbrils, the pro-
tein molecules that compose the ﬁbrils (partially) lose their
native conformation and generally adopt ordered, stacked
cross-b-sheet structures (6–13). Hydrogen bonds and hydro-
phobic interactions between the peptide molecules seem to be
essentially responsible for this assembly process. Despite the
recent advances in the theoretical and experimental tech-
niques to understand the protein aggregation process, the
underlying mechanisms have proved challenging to study.
This is essentially due to the irreversibility of protein aggre-
gation under ambient temperature and pressure conditions,
which complicates or even prohibits the analysis of the under-
lying kinetic and thermodynamic parameters.
Islet amyloid polypeptide (IAPP) or amylin is a 37 amino
acid residue peptide hormone that is cosynthesized and cose-
creted with insulin by pancreatic b-cells (14,15 and Scheme
1). Several functions have been associated with the soluble
form of this hormone (16–18), including the control of hy-
perglycemia by restraining the rate at which dietary glucose
enters the bloodstream. The native structure of IAPP is un-
known, although in aqueous buffer it seems to have a random-
coil-like conformation, indicating that it may be a natively
unfolded protein. It is clear from several reports that human
IAPP (hIAPP) is able to interact with membranes (19–29),
and it seems that the interaction results in the formation of
ﬁbrillar amyloid deposits in the extracellular matrix of the
b-cells leading to membrane damage. Details of the nature of
this interaction are still not known. These deposits are pres-
ent in ;95% of TIIDM patients and are strongly associated
with islet b-cell degeneration and loss (30–32). Some studies
have suggested that binding of hIAPP to the cell membrane
is followed by loss of lipids from the membrane (23,33),
whereas other reports propose insertion of hIAPP into the
membranes (25,34). But it has also been observed that phos-
pholipids are able to catalyze hIAPP amyloid formation, leav-
ing the lipid bilayer intact (35).
Also, it is still unclear which of the hIAPP species, mono-
mers, oligomers, protoﬁbrils, or mature ﬁbrils are mainly in-
volved in these membrane interactions. Several studies have
indicated that hIAPP oligomers, and not the ﬁbrils, may be
involved in the interaction with membranes (20,27,36–39).
According to Porat et al. (24), oligomers are believed to be
intermediate species in the formation of hIAPP amyloid
ﬁbrils. Another report pointed to the possible role of hIAPP
monomers in membrane interactions (33). It has also been
suggested that the process of hIAPP amyloid formation and
not the presence of a particular hIAPP species is related to its
cytotoxicity (25,33–35). A recent publication showed that
freshly dissolved hIAPP has a pronounced ability to insert
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into lipid monolayers with the N-terminal part of the peptide
playing the major role, but not ﬁbrillar hIAPP (19).
Interestingly, the rat or mouse variant of IAPP cannot form
amyloid ﬁbrils although it differs in only 6 out of 37 amino
acids residues (Scheme 1). Although mouse models of dia-
betes require genetic alterations of lipid metabolism and/or
an extremely high fat diet (40), transgenic rat or mouse ex-
pressing hIAPP become strongly predisposed to diabetes and
have higher rates of b-cell loss (41,42). However, it has been
shown that both freshly dissolved mouse and hIAPP have a
similar ability to insert into phospholipid monolayers (19).
These various results on the hIAPP-membrane interaction
indicate that the interaction between hIAPP and lipid mem-
branes is still far from being understood. In particular, the
corresponding secondary structural changes of IAPP induced
upon interaction with membranes are largely unknown. The
main aim of this study was to obtain new insights into the
conformational dynamics of IAPP upon its aggregation at
membrane surfaces and to relate these structures to its ﬁbril
formation. We investigated the interaction of hIAPP and rat
IAPP (rIAPP) at the water-air and water-lipid (1-palmitoyl-2-
oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (POPG) and
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC))
interfaces to test the effect of a strongly hydrophobic inter-
face as well as charged and noncharged lipid interfaces on
the IAPP aggregation process using infrared reﬂection ab-
sorption spectroscopy (IRRAS). IRRAS has proven to be a
very valuable method for the study of lipid-protein interac-
tions by the analyses of the contours of the amide I and II
bands in recent years and is the only method capable of mon-
itoring directly, in situ, the protein’s secondary structure and
its orientation associated with lipid ﬁlms, also in a time-
dependent fashion and as a function of the lipid monolayer
pressure (43–48). To yield additional information on themor-
phological changes in the IAPP under the various interfacial
conditions, an atomic force microscopy (AFM) analysis of
the samples was carried out as well.
MATERIALS AND METHODS
Materials
Synthetic hIAPP was obtained from Calbiochem-Novabiochem (Bad Soden,
Germany) and rIAPP from Bachem (Bubendorf, Switzerland). NaH2PO4
and NaCl were purchased from Gibco BRL (Stockholm, Sweden), 2,2,2-
triﬂuoroethanol (TFE) (grade 991%)was obtained fromAldrich (Milwaukee,
WI). POPG and POPC were from Avanti Polar lipids (Birmingham, AL).
Chloroform and methanol were purchased from Roth (Karlsrule, Germany).
The reagents used were of the highest analytical grade available. For all ﬁlm
balance measurements, deionized water with a resistivity of 18.2 MV cm (SG
Wasseraufbereitung und Regenerierstation, Barsbu¨ttel, Germany) was used.
Lipid monolayer preparation and
protein adsorption
The experiments were performed with a Wilhelmy ﬁlm balance (Riegler &
Kirstein, Berlin, Germany) using a ﬁlter article as Wilhelmy plate (for de-
tails, see Kerth et al. (47), Maltseva et al. (48), and Meister et al. (49)). Two
Teﬂon troughs of different sizes (3003 603 3 mm3 and 603 603 3 mm3
for the reference trough) were linked by three small water-ﬁlled bores to
ensure equal height of the air-H2O interface in both troughs. The temperature
of the subphase was maintained at 20C 6 0.5C and a Plexiglas hood cov-
ered the trough to minimize the evaporation of H2O (49). All experiments
were performed in the small (reference) trough, the large trough ﬁlled with
buffer solution (10 mM NaH2PO4 and 100 mM NaCl) only. Protein ad-
sorption experiments at the air-water interface were started by ﬁlling the
protein-containing buffer solution into the small trough just before running
the infrared reﬂection absorption (IRRA) measurements. The lipid-protein
interactions were studied at constant surface area by ﬁlling the protein-
containing buffer solution into the small trough. Then the uppermost thin
layer of the air-protein-buffer interface was sucked off just before the lipid
monolayers were formed by directly spreading the lipid solution (;1 mM)
in a mixture of chloroform and methanol (3:1) onto the subphase until the
required surface pressure was reached. The protein solutions were prepared
from a stock solution of 125 mM in 100% TFE as follows: The amount of
protein required for each concentration was pipetted into a volumetric ﬂask,
dried with N2, and then resuspended in 10 mM NaH2PO4 buffer with 100
mM NaCl right before the start of the experiment.
Infrared reﬂection absorption spectroscopy
Infrared spectra were recorded with an Equinox 55 FTIR spectrometer
(Bruker, Karlsruhe, Germany) connected to an XA 511 reﬂection attachment
(Bruker) with an external narrow band mercury-cadmium-telluride detector
using the trough system described above (for details, see Meister et al. (49)).
The infrared beamwas focused by several mirrors onto the water surface, and
different angles of incidence could be adjusted. The trough system was
positioned on amovable platform to be able to shuttle between the sample and
the reference trough. This shuttle technique diminishes the spectral interfer-
ences due to the water vapor absorption in the light beam (43). IRRAS was
applied to detect the presence of the peptide and its secondary structure in the
adsorbed state. Comparing the amide I band spectra taken with p-polarized
light and varying the incident angle allows getting information about the
orientation of the peptide, as p-polarized light probes the transition dipole
moment components parallel and perpendicular to the surface. The measured
signal can contain positive and negative bands, depending on the angle of
incidence and orientation of the transition dipole moment with respect to the
interface. At a given angle of incidence above the Brewster angle, positive
intensities suggest a transition dipole moment oriented preferentially in the
plane of the surface, and negative bands reﬂect a perpendicular orientation.
The single-beam reﬂectance spectrum of the reference trough surface was
ratioed as background to the single-beam reﬂectance spectrum of the mono-
layer on the sample trough to calculate the reﬂection absorption spectrum as
log(R/R0).
Atomic force microscopy
Samples were carefully collected in the surface area at the end of the IRRAS
experiments, and 5 mL of the dispersion was applied onto freshly cleaved
muscovite mica and allowed to dry. The AFM measurements were per-
formed at room temperature using the MultiModeAFM of Veeco (Santa
Barbara, CA) in the TappingMode. Silicon tips (RTESP, Veeco) were used
SCHEME 1 Primary sequences of human and rIAPP. The amino acid res-
idues marked in light gray belong to the ‘‘amyloidogenic core’’ proposed for
IAPP. The six amino acid residues drawn in dark gray highlight the dif-
ferences between the two sequences.
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with a maximal curvature radius of 12.5 nm and a resonance frequency of
292 kHz. The maximum scan rate was 1 Hz.
RESULTS
IAPP adsorption at the water-air interface
The main aim of our study was to obtain structural insights
into the conformational dynamics of IAPP upon aggregation
at various interfaces including lipid membranes and to relate
these structures to ﬁbril formation. To this end, we ﬁrst in-
vestigated the process of hIAPP aggregation at the air-water
interface, which represents an idealized hydrophobic model
interface as a function of peptide concentration and time. Ex-
periments were performed at hIAPP concentrations, starting
with 200 nM up to 1 mM. For the lower, submicromolar con-
centrations, an increase in the surface pressure (P) values
is observed and a surface pressure plateau is reached (after
3 h, 20 mN/m for 400 nM hIAPP), which indicates the high
surface activity of hIAPP. The frequency of the amide I
band is typical for an a-helical conformation (1655 cm1)
and remains constant even after 20 h (data not shown). A
concentration of 1 mM of hIAPP results in a fast increase
in the surface pressure, however, which is followed by a
plateau starting;1 h after the beginning of the experiment
(Fig. 1 A).
As clearly seen in Fig. 1 B, the increase in the surface
pressure is accompanied by a slow change in the secondary
structure of the peptide: The wavenumber of the amide I band
is centered at ;1655 cm1, typical for a-helical conforma-
tions, during the ﬁrst hours. After;10 h, the band maximum
shifts to ;1625 cm1 (typical for b-sheet conformations),
accompanied by a small peak at 1671 cm1 (representing
b-turns). After ;20 h, the end of the adsorption process and
the ﬁnal state is reached. In the amide II band region, con-
comitant but smaller changes occur. The band at 1540 cm1
disappears and a peak at 1523 cm1 develops with time, again
revealing the transition from a largely a-helical to a b-sheet
structure. Amide II bands are rarely used for quantitative
secondary determinations and are hence not further discussed
here.
Human IAPP adsorption at the
water-lipid interface
To elucidate if hIAPP interactions with lipid model mem-
branes occur via a simple binding process to the surface or if
actual insertion of IAPP into the membrane is involved, and
to reveal the accompanying peptide conformational changes
taking place, we performed IRRAS measurements with lipid
ﬁlms of different charge and packing properties. In a ﬁrst set
of experiments, we used a POPC lipid ﬁlm as a zwitterionic
lipid layer and took IRRA spectra at different conditions of
surface pressure after adding the peptide. For all conditions,
no changes in the surface pressure proﬁle and no interaction
between the peptide and lipid ﬁlm as indicated by the ab-
sence of an absorption band in the amide wavenumber re-
gion was observed over a similarly long time period (data not
shown).
The lack of IAPP-POPC interaction suggests that the dom-
inant factor for IAPP-lipid interaction is an electrostatic inter-
action between the positively charged N-terminal amino acid
residue and negatively charged and strongly polar lipid head-
groups. To address this point, we performed IRRAS ex-
periments with POPG, a negatively charged monolayer ﬁlm.
Fig. 2 exhibits the surface pressure as a function of time and
the corresponding IRRA spectra, revealing the correlation
with changes in the protein structure. In the ﬁrst set of ex-
periments (Fig. 2, A and B), the surface pressure was initially
set to 10 mN/m. We clearly observe a different scenario from
that at the air-water interface: The surface pressure increases
rapidly, achieving a ﬁrst plateau of 25 mN/m in;2 h and then
increases slightly until it reaches a second plateau value of
;32 mN/m after ;20 h. Interestingly, this two-step surface-
pressure proﬁle is accompanied by a concomitant two-step
protein conformational change. The wavenumber of the amide
I band with initial values around 1658 cm1, typical for
a-helical conformational states, transforms to two clearly dis-
tinguishable peaks after;4–5 h of the experiment—i.e., when
reaching the ﬁrst plateau, one intense, narrow band at 1625
cm1 and a smaller peak at 1671 cm1—representing forma-
tion of (parallel) intermolecular b-sheets and b-turns, respec-
tively.
FIGURE 1 (A) Surface-pressure ver-
sus time course of hIAPP ﬁlm adsorbed
at the water-air interface (1 mM hIAPP
subphase concentration) and (B) IRRA
spectra of the hIAPP ﬁlm at the re-
spective positions of the surface-pressure
versus time curve given in A.
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Assuming a constant orientation of the infrared transition
dipole moments upon protein adsorption, a rough estimation
of the changes in amide I band intensity (reﬂecting the amount
adsorbed at the lipid interface) and the relative changes of
secondary structure elements may be performed (Fig. 3,A and
B). As seen in Fig. 3 B, a decrease in a-helical and b-turn
content starts around 2 h, which is accompanied by a con-
comitant increase in intermolecular b-sheet structures. After
;10 h, most of the protein seems to be adsorbed (Fig. 3 A),
whereas conformational changes are still proceeding—at a
smaller rate, however. A similar behavior was observed when
the same experiment was performed with an initial surface
pressure of 20 mN/m. The respective two plateaus forPwere
observed at 28mN/m in;1 h and at;35mN/m after 7 h. The
corresponding spectral changes in the amide I band region,
concerning intensity and position of peaks, are similar (data
not shown).
The packing density of lipids in biological bilayer mem-
branes corresponds to P-values of ;31–35 mN/m (50). To
also test the ability of IAPP to insert into bilayer membranes,
we performed experiments starting at a surface pressure
value of 30 mN/m (Fig. 2, C and D). The results are even
more striking. The time-dependent increase of P reveals a
strong interaction and even insertion of the protein into the
POPG monolayer, reaching a limiting surface pressure of
;40 mN/m. The appearance of spikes in the surface pressure
proﬁle can be explained by a transient rearrangement and
relaxation of the lipid ﬁlm upon insertion of the peptide. The
ﬁrst spectral changes in the amide I band region are much
faster and take place in the ﬁrst 2 h of the experiment. After a
similar scenario as discussed above for the lower initial
P-values and demonstrated in Fig. 3, the peaks at ;1623–
1626 cm1 evolve with time, with much higher intensity
values, however.
The similarly large increase of surface pressure of 7–9
mN/m (which is roughly independent of the initial P-value)
upon addition of the peptide strongly suggests that hIAPP is
able to insert into the POPG membrane. The limiting surface
pressure is signiﬁcantly higher than the surface pressure that
corresponds to the packing density of lipids in natural mem-
branes. Hence, IAPP is also able to insert into biological
membranes in vivo. Furthermore, the data indicate that upon
FIGURE 2 (A) Surface-pressure versus time course of a POPG ﬁlm with 1 mM hIAPP and (B) IRRA spectra of the amide I and II regions for POPG
monolayer starting at 10 mN/m at the respective positions of the surface-pressure versus time curve given in A. (C) Surface-pressure versus time course of a
POPG ﬁlm with 1 mM hIAPP and (D) IRRA spectra of the amide I and II regions for POPG monolayer starting at 30 mN/m at the respective positions of the
surface-pressure versus time curve given in C. All IRRA spectra were acquired using p-polarized light at an angle of incidence of 40.
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insertion of the protein a conformational transition from a
largely a-helical to a b-sheet conformation with a signiﬁcant
contribution of b-turns takes place. The appearance of the
intense sharp peak at ;1625 cm1 indicates formation of a
strong protein network with parallel b-sheet arrangement in
the interfacial region. It appears that the higher the surface
pressure values, the stronger the cohesion of the adsorbed
protein network becomes.
All experiments were performed with IAPP in 10 mM
phosphate buffer with 100 mM NaCl at pH 7.4. At this pH,
the only charged residue in the N-terminal region is the ﬁrst
lysine residue with one positive charge, hence suggesting
that this part of the protein may be responsible for the in-
sertion, as also suggested for a different anionic lipid system
(19). However, as for a sufﬁciently strong interaction with
the lipid system, generally more than one charge is needed;
in particular under charge screening conditions (100 mM
NaCl), N-terminal anchoring into the lipid layer is very likely
to be operative as well.
Rat IAPP adsorption at the water-lipid interface
Supposing that the N-terminal sequence of IAPP is respon-
sible for the insertion into the lipid membrane, rIAPP should
also be able to insert into the POPG lipid ﬁlm. To test this
hypothesis, we performed an additional experiment using a
POPG ﬁlm starting with 20 mN/m surface pressure (Fig. 4, A
and B). As clearly visible in Fig. 4 A, rIAPP is also able to
insert into these lipid monolayers with a-helical conforma-
tion, and a similar pronounced increase of the surface pres-
sure (up to;31 mN/m) is observed. However, no signiﬁcant
changes are observed in the amide I band region except for a
decrease in the amide I band intensity during the whole ad-
sorption process. These results clearly support previous as-
sumptions that the N-terminus of IAPP is not involved in the
aggregation process itself but rather in the insertion process
into the lipid membrane only (51–53). Lorenzo et al. (54)
showed that rIAPP does not cause the same toxic effect as
hIAPP, which is in line with the notion that secondary b-sheet
organization and aggregation are important for membrane
damage.
Orientation of hIAPP at the lipid interface as
revealed from simulations of the amide I
band region
The secondary structure prediction for hIAPP is shown in
Scheme 2 (51,55–58). The protein has 37 amino acid resi-
dues and a very hydrophobic core, which appears respon-
sible for the high aggregation tendency of IAPP. According
to the literature, aggregation of the C-terminal domain of
IAPP (amino acid sequences 20–29 and 30–37) is thought
to be most likely driven by hydrophobic interactions (see
Scheme 1). The distinct amyloidogenic region 20–29 has
been pointed out to be a key ﬁbril-forming region (58). In-
deed, it is conceivable that the C-terminus of IAPP, spanning
residues 20–37, forms a contiguous b-sheet. The secondary
structure predictions of IAPP indicate that there is a potential
a-helical region in hIAPP between amino acid residues 8–14,
and three potential b-strand regions. A b-turn segment has
been predicted at Asn-31, which could result in two adjacent
b-strands (.24 and.32), eventually creating an antiparallel
b-sheet.
The s-polarized light probes only the transition dipole mo-
ment component parallel to the surface, whereas p-polarized
light probes the dipole moment components parallel and
perpendicular to the surface. As a consequence of the latter,
the sign of the band changes around the Brewster-angle and
the resulting changes in band shape, intensity, and position
allow the determination of orientation of secondary structure
elements (47–49). The transition dipole moment of the major
b-sheet component at ;1627 cm1 is oriented along the
FIGURE 3 (A) Time dependence of the intensity of the amide I band
region of 1 mM hIAPP at the POPG monolayer at a surface pressure of 10
mN/m. (B) Corresponding changes of the secondary structure elements.
Owing to unknown transition dipole moments, only relative changes should
be discussed.
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plane of the interchain hydrogen bond, perpendicular to the
peptide chain. We performed IRRAS measurements using
p-polarized light at different angles of incidence at surface
pressure values in the pressure plateau regions to reveal the
orientation of the developing cross-b-structure at the water-
air and water-lipid interface, respectively.
For the measurements with hIAPP at the water-air inter-
face, the surface pressure was 23.6 mN/m (data not shown).
For the corresponding measurements of hIAPP at the POPG
interface, the pressure was 32.2 mN/m and similar data sets
were obtained (Fig. 4 C). Simulations of the amide bands for
a b-sheet orientation of IAPP at the POPG interface parallel
to the interface with different angles of incidence and use of
p-polarized light are shown in Fig. 4 D. Comparison of the
simulated and measured spectra reveals that IAPP sheets are
in fact lying ﬂat at the water-charged phospholipid monolayer
FIGURE 4 (A) Surface-pressure versus time course of a POPG ﬁlm with 1 mM rIAPP and (B) IRRA spectra of the lipid ﬁlm at the respective positions of the
surface-pressure versus time curve given in A (please note the drastically expanded intensity scale). All spectra were recorded at an angle of incidence of 40
with p-polarized light. (C) IRRA spectra of 1 mM hIAPP adsorbed at the water-POPG monolayer interface acquired with p-polarized light at various incident
angles and a surface pressure of 32.2 mN/m. (D) Simulations of IRRA spectra of a b-sheet lying ﬂat at the water-air interface. The calculation was performed
for p-polarized light and different angles of incidence for the amide I and II band regions.
SCHEME 2 Representation of secondary structure predictions for hIAPP (algorithms used (51,55–58): 1: double prediction; 2: hierarchical neural network
classiﬁers; 3: self-optimized prediction method).
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interface, and layering of the b-sheets parallel to the lipid
interface seems to be very likely. The orientation of the b-sheets
at the water-air interface is similar (spectra not shown).
AFM data on the morphology of IAPP aggregates
The AFM images of 1 mM IAPP aggregated at the POPG
interface exhibit IAPP ﬁlaments with a width of;35–70 nm
and a height of;3–5 nm (Fig. 5 A). These dimensions are in
fact characteristic for ﬁbrillar structures of amyloidogenic
proteins (59–65). The ﬁbril widths in AFM images appear
much larger due to the dependence on the size and shape of
the scanning AFM tip (of ;10 nm radius) used for imaging.
Hence, ﬁbril heights in AFM are generally a more accurate
structural feature and are commonly used to characterize ﬁ-
bril types. The basic structural units of protein ﬁbrils, the
protoﬁlaments, are generally of the order of 2–5 nm in di-
ameter and appear to be composed of between two and six
b-sheets, depending on the protein under investigation. These
protoﬁlaments twist together to form rope-like ﬁbrils that are
typically 7–13 nm wide or associate laterally to form long
ribbons that are 2–5 nm thick and up to ;30 nm wide (65).
Variations in the average ﬁbril height may be ascribed to dis-
crete populations of ﬁbrils containing various numbers of the
protoﬁlaments that make up the ﬁbril substructure. The heights
in the range as observed here might correspond to the size of
just one or two protoﬁlaments (65–67). As the molecular
structure of hIAPP and the ﬁbrillar building blocks are still
largely unknown, no further structural details can be given.
AFM images were also taken for a sample of rIAPP (1 mM).
The sample was taken after 20 h from the POPG interface.
Small oligomeric structures with a height of ;3 nm are seen
only; no ﬁbrillar structures could be detected (Fig. 4 B).
DISCUSSION AND CONCLUSIONS
In this study, we performed lipid monolayer experiments in
combination with IRRAS studies to obtain insight into the
nature and the molecular details of the initial steps of the
hIAPP-membrane interaction and subsequent ﬁbrillation pro-
cess.We have clearly seen that hIAPP is able to interact strongly
with negatively charged lipid membranes (POPG) only. IAPP
binds most likely through electrostatic interactions by inser-
tion of the N-terminal part of the peptide—in an a-helical
conformation—and then, after a lag time that depends on the
surface pressure and the peptide concentration, the conver-
sion to a b-sheet structure and ﬁbril formation takes place,
suggesting that the a-helical structures preorganize the peptide
into larger assemblies (Fig. 6). The observed lipid-induced
transient a-helix formation by IAPP thus reﬂects an inter-
mediate of amyloid formation but seems to also be important
for anchoring at and (partial) insertion into the membrane, as
the mature ﬁbrillar form is not able to interact with the lipid
ﬁlm, as also observed for a similar lipid monolayer system
(19).
Indeed, amino acid residues 8–14 of IAPP have been pre-
dicted to be a-helical, and residues 8–20 can be induced
to form ﬁbrils when isolated (60). The resulting increased
concentration of the peptide and the reduced dimensionality
FIGURE 5 (A) AFM image of the aggregate struc-
ture of IAPP (1 mM), formed at and taken from
underneath the POPG interface and deposited on
freshly cleaved mica. Filaments with a width of;70
nm and a height of ;4 nm are found. (B) AFM
image of a sample of rIAPP (1 mM), taken from the
POPG interface after 20 h. Some small oligomeric
or amorphous structures with a height of;3 nm are
seen only.
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facilitates interaction of the membrane-bound a-helical pep-
tides, ﬁnally leading to the formation of ﬁbrillar b-sheet struc-
tures. As indicated by the IRRA spectra, the ﬁbrillar structure
formed probably consists of parallel intermolecular b-sheets
but still contains a signiﬁcant amount of turn structures. In
fact, it has been suggested that, with the N-terminus partially
inserted into the lipid bilayer, parallel helix-helix orientation
and hence subsequent accelerated conversion to b-sheets with
antiparallel b-strand alignment in a cooperative manner may
be expected (28).
Interestingly, a similar transformation process holds for
the aggregation of hIAPP at a purely hydrophobic (water-air)
interface. Hence, from these results we can conclude that
hIAPP readily adsorbs at hydrophobic as well as anionic hy-
drophilic surfaces; however, ﬁbril formation takes place at
the anionic lipid interface only as revealed by the AFM data.
At the purely hydrophobic interface, small amorphous aggre-
gate structures are formed only. In accord with mouse IAPP
studies (19), our data also indicate that nonamyloidogenic
rIAPP also has a pronounced ability to insert into negatively
charged phospholipid membranes and form a-helical struc-
tures and that the N-terminal part of the peptide is respon-
sible for the insertion process and is not part of the ﬁbril core.
Interestingly, (transient) helix formation has been suggested
to occur favorably in natively unstructured amyloidogenic
proteins (61–64). The Ab peptide—involved in Alzheimer’s
disease—is a-helical in micellar conﬁnement and has been
shown to sample in an a-helical state in aqueous solution
before its transformation to amyloid ﬁbrils (62,63).Also theN-
terminus of a-synuclein—involved in Parkinson’s disease—
forms helices whose stability affects amyloid formation and
toxicity (64). Preassembly of a-helices may therefore be a
rather common factor affecting amyloid formation by natively
unstructured peptides.
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